Skip to main content
Clinical Trials/JPRN-UMIN000018608
JPRN-UMIN000018608
Recruiting
未知

A Multicenter, Prospective, Cohort Study Examining the Incidence of Metachronous Cancer in Other Organs According to the Grade of Lugol-voiding lesion (LVL) after Curative Endoscopic Resection of Early Esophageal Cancer - Japan Esophageal Cohort study - 2 (JEC-2)

AMED0 sites385 target enrollmentAugust 10, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Esophageal squamous cell carcinoma
Sponsor
AMED
Enrollment
385
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 10, 2015
End Date
October 31, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
AMED

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Registration in the JEC\-1 study 2\) A history of chemotherapy (including molecular targeted therapies) 3\) A history of radiotherapy or surgical resection for head and neck cancer or esophageal cancer 4\) Active double cancers in other organs (However, intramucosal cancers of other organs are not regarded to be active cancers in other organs.) 5\) An allergy to iodine 6\) Patients considered by their attending physicians to be unsuitable for enrollment in this study

Outcomes

Primary Outcomes

Not specified

Similar Trials